About this trial
This study is a 4-visit, multi-site, prospective, controlled, randomized, single-masked (subjects), two-arm parallel group, bilateral, dispensing clinical trial to compare the performance of the Test lens to the Control lens in terms of safety and efficacy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
Appear able and willing to adhere to the instructions set forth in this clinical protocol.
Be at least 40 years of age and not greater than 70 years of age at the time of consent.
Own a wearable pair of spectacles if required for their distance vision.
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Senofilcon A
DeviceACUVUE® Oasys MAX 1-Day Multifocal
Nelfilcon A
DeviceDAILIES® AquaComfort Plus® Multifocal
Treatment groups
Trial outcomes
Primary outcomes
Mean binocular HLHC distance Visual Acuity
Mean binocular HLHC VA at distance (4m)
Mean binocular HLHC Intermediate Visual Acuity
Mean binocular HLHC VA at Intermediate (64cm)
Mean binocular HLHC Near Visual Acuity
Mean binocular HLHC VA at Near (40cm)
Incidence rate of study-lens related (i.e. related and possibly related) ocular adverse events.
Secondary outcomes
Mean binocular HLHC distance Visual Acuity
Mean binocular HLHC VA at distance (4m)
Mean binocular HLHC Intermediate Visual Acuity
Mean binocular HLHC VA at Intermediate (64cm)
Mean binocular HLHC Near Visual Acuity
Mean binocular HLHC VA at Near (40cm)
Incidence rate of Slit Lamp Findings (SLF)
Slit lamp findings will be assessed for each eye at all study visits (scheduled and unscheduled) by grade. SLFs will be evaluated and graded using the ISO 11980 Grading scale from 0 to 4, where Grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e., Grade 1 = trace, Grade 2 = mild, Grade 3 = moderate and Grade 4 = severe).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.